T2 Biosystems (NASDAQ:TTOO – Get Free Report) will release its earnings data after the market closes on Monday, May 6th. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
T2 Biosystems Stock Up 1.9 %
NASDAQ:TTOO opened at $3.72 on Friday. T2 Biosystems has a fifty-two week low of $2.60 and a fifty-two week high of $70.00. The firm’s fifty day simple moving average is $3.63 and its 200-day simple moving average is $4.46.
Analyst Ratings Changes
Separately, Canaccord Genuity Group lowered their target price on T2 Biosystems from $12.00 to $3.00 and set a “hold” rating on the stock in a report on Monday, April 29th.
About T2 Biosystems
T2 Biosystems, Inc, an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
See Also
- Five stocks we like better than T2 Biosystems
- Following Congress Stock Trades
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- High Flyers: 3 Natural Gas Stocks for March 2022
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Investing in Construction Stocks
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
